Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Wednesday, April 14, 2021

Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain

paythelady.612 shared this article with you from Inoreader

World J Clin Cases. 2021 Mar 26;9(9):2100-2109. doi: 10.12998/wjcc.v9.i9.2100.

ABSTRACT

Neuropathic pain (NPP) is a kind of pain caused by disease or damage impacting the somatosensory system. Ion channel drugs are the main treatment for NPP; however, their irregular usage leads to unsatisfactory pain relief. To regulate the treatment of NPP with ion channel drugs in clinical practice, the Chinese Association for the Study of Pain organized first-line pain management experts from China to write an expert consensus as the reference for the use of ion channels drugs . Here, we reviewed the mechanism and characteristics of sodium and calcium channel drugs, and developed recommendations for the therapeutic principles and clinical practice for carbamazepine, oxcarbazepine, lidocaine, bulleyaconitine A, pregabalin, and gabapentin. We hope this guideline provides guidance to clinicians and patients on the use of ion channel drugs for the mana gement of NPP.

PMID:33850929 | PMC:PMC8017507 | DOI:10.12998/wjcc.v9.i9.2100

View on the web

No comments:

Post a Comment